The limited availability of ALK IHC in previously reported cases makes it difficult to draw definitive conclusions regarding the association between ALK1 status and tumor recurrence in laryngeal IMT [21]. The gene discussed is ALK; the disease is inflammatory myofibroblastic tumor.